Oxcarbazepine
NDC 68999-841, Oxcarbazepine, suspension, from Chartwell Governmental & Specialty RX, LLC..
- Product NDC
- 68999-841
- Status
- Listed
- Labeler
- Chartwell Governmental & Specialty RX, LLC.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212428
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68999-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE300 mg/5mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68999-841-24 | 68999084124 | 2 TRAY in 1 BOX (68999-841-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (68999-841-45) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e74bb389-8426-4ffc-a14b-a5990de6d0d4
Use it
Look up 68999-841 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68999-841 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68999-841. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.